Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,057 public trials 2,038 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Safety and Tolerability of XmAb®5574 in Chronic Lymphocytic Leukemia

NCT01161511

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations: Medical College of Georgia Augusta, Georgia, United States

The Ohio State University Columbus, Ohio, United States

Sarah Cannon Research Institute Nashville, Tennessee, United States

View Trial Details

Completed

Safety Study of XmAb®2513 to Treat Hodgkin Lymphoma or Anaplastic Large Cell Lymphoma

NCT00606645

Conditions: Anaplastic Large Cell Lymphoma, Hemic and Lymphatic Diseases, Hodgkin Disease, +11 more
Locations: Rush University Medical Center Chicago, Illinois, United States

Ohio State University Columbus, Ohio, United States

Fox Chase Cancer Center Philadelphia, Pennsylvania, United States

MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

CCI-779 and Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

NCT00109967

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Mobile Infirmary Medical Center Mobile, Alabama, United States

The Medical Center of Aurora Aurora, Colorado, United States

Boulder Community Hospital Boulder, Colorado, United States

Penrose-Saint Francis Healthcare Colorado Springs, Colorado, United States

View all 195 locations

View Trial Details

Completed

PAV-trial: Plerixafor and Chemotherapy With Vinorelbine for Stem Cell Mobilization in Patients With Myeloma

NCT01220375

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Dep. of Medical Oncology, Bern University Hospital Bern, Switzerland

View Trial Details

Completed

Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer

NCT00265837

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +64 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Completed

Labial Biopsy in Patients With Tuberculosis Disease

NCT02115854

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +11 more
Locations: Unite de Recherche Thérapeutique Paris, France

View Trial Details

Completed

Melphalan and Palifermin in Treating Patients Undergoing An Autologous Peripheral Stem Cell Transplant for Stage II or III Multiple Myeloma

NCT00482846

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chemically-Induced Disorders, +20 more
Locations: Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details

Completed

A Study of Clofarabine in Combination With Etoposide and Cyclophosphamide in Children With Acute Leukemias.

NCT00315705

Conditions: Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Hematologic Diseases, +13 more
Locations: Children's Hospital of Alabama Birmingham, Alabama, United States

Children's Hospital of Los Angeles Los Angeles, California, United States

Rady Children's Hospital San Diego, California, United States

Connecticut Children's Medical Center Hartford, Connecticut, United States

View all 13 locations

View Trial Details

Completed

Bryostatin 1 in Treating Patients With Recurrent or Refractory Hodgkin's Disease

NCT00003936

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +6 more
Locations: Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details

Completed

Induction Therapy With Cytarabine, High-Dose Mitoxantrone and Dasatinib for Patients With Philadelphia-Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia

NCT00940524

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Lymphoproliferative Disorders

Lymphoproliferative Disorders trial results

Related conditions